Lisa Chambers (Mayo, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

134. To ask the Minister for Health the financial assistance that will be available for IVF from 2019; and if he will make a statement on the matter. [38075/18]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

As the Deputy may be aware, the Government approved the drafting of a Bill on assisted human reproduction (AHR) and associated areas of research in October last year and officials in my Department are engaging with the Office of the Attorney General in relation to the process of drafting this Bill. The General Scheme is published on my Department’s website and the Joint Committee on Health is currently conducting a review of the General Scheme of the Assisted Human Reproduction Bill 2017 as part of the pre-legislative scrutiny process, which began in January of this year. The introduction of legislation in relation to AHR and associated research is a priority for me.

In order to support the commencement of the legislation, officials in my Department are working with the HSE over the course of this year in developing a model of care for infertility to ensure the provision of safe, effective and accessible services through the public health system as part of the full range of services available in obstetrics and gynaecology.

Part of this work includes identifying policy options for a public funding model for AHR treatment. Once I have had the opportunity to consider these policy options I will bring a Memorandum to Government in relation to a model of care for infertility, including public funding for AHR treatment, for the Government's consideration.

It should be noted that any funding model that may ultimately be introduced would need to operate within the broader regulatory framework set out in the AHR Bill and a model of care for infertility.

Currently, patients who access IVF treatment privately may claim tax relief on the costs involved under the tax relief for medical expenses scheme. In addition, a defined list of fertility medicines needed for fertility treatment is covered under the High Tech Scheme administered by the HSE. Medicines covered by the High Tech Scheme must be prescribed by a consultant/specialist and approved by the HSE ‘High Tech Liaison Officers’. The cost of the medicines is then covered, as appropriate, under the Medical Card or Drugs Payment Scheme. There is also a limited specialist AHR service available through the HSE, which provides funding for fertility preservation for cancer patients whose treatment is likely to impact on their future fertility.